Ask Warren

Selvas Healthcare

208370 · KOSDAQ · ₩208370 · 셀바스헬스케어

₩2,110▼ ₩70 (3.21%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩8.2B₩6.6B₩10B₩6.7B₩6.7B₩7.2B₩9.2B₩8.6B
Cost of sales₩4.1B₩3.3B₩5.3B₩3.5B₩3.6B₩3.5B₩4.4B₩3.9B
Gross profit₩4.1B₩3.2B₩4.9B₩3.2B₩3.1B₩3.7B₩4.7B₩4.7B
Operating income₩372M₩669M−₩22M₩541M−₩1B₩349M₩1.1B₩1.5B
Net income−₩22B₩13B₩3.4B₩965M−₩650M₩194M₩2.9B₩18M
Net income to shareholders−₩8.7B₩13B₩3.6B₩509M−₩456M₩194M₩2.1B₩214M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩85B₩92B₩79B₩71B₩71B₩71B₩70B₩68B
Current assets₩49B₩59B₩46B₩43B₩43B₩43B₩44B₩42B
Cash and equivalents₩3B₩4B₩9.4B₩8.6B₩8.8B₩6.1B₩14B₩11B
Total liabilities₩9.4B₩7.8B₩7.9B₩6.9B₩7.7B₩7.2B₩6.4B₩6.6B
Current liabilities₩6.6B₩4.9B₩5B₩6B₩6.8B₩6.2B₩5.4B₩5.8B
Borrowings₩2B₩750M₩1.1B₩1.3B₩1.9B₩2B₩2.3B₩2.1B
Total equity₩76B₩84B₩71B₩64B₩63B₩64B₩64B₩61B
Shareholders' equity₩76B₩84B₩71B₩64B₩63B₩64B₩64B₩61B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩325M₩1.1B₩1.4B₩838M−₩1.1B−₩811M₩1.9B₩2.4B
Capital spending₩552M₩425M₩255M₩431M₩31M₩139M₩315M₩48M
Free cash flow−₩876M₩667M₩1.1B₩407M−₩1.1B−₩950M₩1.6B₩2.3B

Consolidated where available. Amounts in won.

Also known as: Selvas Healthcare / 셀바스헬스케어 / 208370 / KRX:208370

Source: KRX statistical information